Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Arthrogryposis, Distal, with Mental Retardation and Characteristic Facies | C565940 | |
| 3-(4-methyl-5-oxo-2,5-dihydrofuran-2-yl)oxyimino-3a,4-dihydro-3H-indeno(1,2-b)furan-2(8bH)-one | C526355 | |
| Arteriosclerosis, Severe Juvenile | C565941 | |
| daedalin A | C526356 | |
| Arterial Tortuosity Syndrome | C565942 | |
| Duofluorid-F | C526357 | |
| CLEC2A protein, human | C526358 | |
| 4-(6-acetyl-3-(3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy)-2-propylphenoxy)butyric acid | C526359 | |
| glycoprotein E2, Hepatitis C virus | C091015 | |
| Parodontax | C091016 | |
| RetarDEX oral rinse | C091018 | |
| AMALCODEN | C091019 | |
| Ataxia, Deafness, and Cardiomyopathy | C565932 | |
| Ataxia with Myoclonic Epilepsy and Presenile Dementia | C565933 | |
| Asthma, Short Stature, and Elevated IgA | C565934 | |
| Asthma, Nasal Polyps, And Aspirin Intolerance | C565935 | |
| luteolin 8-C-rhamnoside-7-O-rhamnoside | C091010 | |
| N,N'-bis(5-acenaphthyl)guanidine | C091011 | |
| Scianna antibody | C091012 | |
| MEC protocol 2 | C091013 |